Clinical evaluation to confirm the manufacturing consistency of three lots of an adjuvanted glycoprotein D genital herpes vaccine in healthy seronegative pre-teen and adolescent girls: A phase III multi-center double-blind randomized trial

Trials in Vaccinology

Volumn 2, Issue 1, 2013, Pages 10-18

  Leroux Roels, Geert ^a   Dobson, Simon ^b   Bernstein, David I ^c   Fowler, Sandra ^d   Romanowski, Barbara ^e   Leroux Roels, Isabel ^a   Cheuvart, Brigitte ^f   Heineman, Thomas ^g   Dubin, Gary ^g  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e UNIVERSITY OF ALBERTA   (Canada)

^f GSK   (Belgium)

^g GLAXOSMITHKLINE   (United States)

Author keywords

Herpes simplex virus; Immunogenicity; Lot consistency; Safety; Subunit vaccine

Indexed keywords

GLYCOPROTEIN D; HERPES SIMPLEX VIRUS TYPE 2 VACCINE; HERPES VACCINE; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADOLESCENT; ARTHRALGIA; BELGIUM; CANADA; CHILD; CONTROLLED STUDY; COUGHING; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG MANUFACTURE; DRUG SAFETY; DYSMENORRHEA; FATIGUE; FEMALE; HERPES SIMPLEX VIRUS; HUMAN; IMMUNE RESPONSE; INFLUENZA; INJECTION SITE PAIN; INJECTION SITE REACTION; MALAISE; MULTICENTER STUDY; NAUSEA AND VOMITING; OROPHARYNX PAIN; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RHINOPHARYNGITIS; SCHOOL CHILD; SINUS CONGESTION; SWELLING; UNITED STATES; UPPER RESPIRATORY TRACT INFECTION; URTICARIA;

EID: 84876538379     PISSN: None     EISSN: 18794378     Source Type: Journal    
DOI: 10.1016/j.trivac.2013.03.001     Document Type: Article

References (25)

1. K.J. Looker, G.P. Garnett, and G.P. Schmid An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection Bull. World Health Organ. 86 2008 805 812 A
2. J.S. Smith, and N.J. Robinson Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review J. Infect. Dis. 186 Suppl. 1 2002 S3 S28
3. R.G. Pebody, N. Andrews, D. Brown, R. Gopal, H. De Melker, and G. Francois The seroepidemiology of herpes simplex virus type 1 and 2 in Europe Sex. Transm. Infect. 80 2004 185 191
4. A.M. Eis-Hubinger, E. Nyankiye, D.M. Bitoungui, and J. Ndjomou Prevalence of herpes simplex virus type 2 antibody in Cameroon Sex. Transm. Dis. 29 2002 637 642
5. D.T. Fleming, G.M. McQuillan, R.E. Johnson, A.J. Nahmias, S.O. Aral, and F.K. Lee Herpes simplex virus type 2 in the United States, 1976 to 1994 N. Engl. J. Med. 337 1997 1105 1111
6. F. Xu, M.R. Sternberg, B.J. Kottiri, G.M. McQuillan, F.K. Lee, and A.J. Nahmias Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States JAMA 296 2006 964 973
7. Centers for Disease Control and Prevention (CDC), Seroprevalence of herpes simplex virus type 2 among persons aged 14-49 years-United States, 2005-2008, MMWR Morb Mortal Wkly Rep 59 (2010) 456-459.
8. L. Corey Synergistic copathogens - HIV-1 and HSV-2 N. Engl. J. Med. 356 2007 854 856
9. C. Johnston, D.M. Koelle, and A. Wald HSV-2: in pursuit of a vaccine J. Clin. Invest. 121 2011 4600 4609
10. E.E. Freeman, H.A. Weiss, J.R. Glynn, P.L. Cross, J.A. Whitworth, and R.J. Hayes Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies AIDS 20 2006 73 83
11. E. Anzivino, D. Fioriti, M. Mischitelli, A. Bellizzi, V. Barucca, and F. Chiarini Herpes simplex virus infection in pregnancy and in neonate: status of art of epidemiology, diagnosis, therapy and prevention Virol. J. 6 2009 40
12. A. Chatterjee, S.A. Chartrand, C.J. Harrison, A. Felty-Duckworth, and C. Bewtra Severe intrauterine herpes simplex disease with placentitis in a newborn of a mother with recurrent genital infection at delivery J. Perinatol. 21 2001 559 564
13. Z.A. Brown, J. Benedetti, R. Ashley, S. Burchett, S. Selke, and S. Berry Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor N. Engl. J. Med. 324 1991 1247 1252
14. G.L. Armstrong, J. Schillinger, L. Markowitz, A.J. Nahmias, R.E. Johnson, and G.M. McQuillan Incidence of herpes simplex virus type 2 infection in the United States Am. J. Epidemiol. 153 2001 912 920
15. L.R. Stanberry, S.L. Spruance, A.L. Cunningham, D.I. Bernstein, A. Mindel, and S. Sacks Glycoprotein-D-adjuvant vaccine to prevent genital herpes N. Engl. J. Med. 347 2002 1652 1661
16. D.I. Bernstein, F.Y. Aoki, S.K. Tyring, L.R. Stanberry, C. St-Pierre, and S.D. Shafran Safety and immunogenicity of glycoprotein D-adjuvant genital herpes vaccine Clin. Infect. Dis. 40 2005 1271 1281
17. European Medicines Agency, Note for guidance on the clinical evaluation of vaccines. Available from: < http://www.ema.europa.eu/docs/en-GB/document- library/Scientific-guideline/2009/09/WC500003875.pdf > (accessed June 2012).
18. World Health Organization, Clinical considerations for evaluation of vaccines for prequalification. Points to consider for manufacturers of human vaccines. Available from: < http://www.who.int/immunization-standards/ vaccine-quality/clinical-considerations-oct10.pdf > (accessed June 2012).
19. R.B. Belshe, P.A. Leone, D.I. Bernstein, A. Wald, M.J. Levin, and J.T. Stapleton Efficacy results of a trial of a herpes simplex vaccine N. Engl. J. Med. 366 2012 34 43
20. R. Ashley, A. Cent, V. Maggs, A. Nahmias, and L. Corey Inability of enzyme immunoassays to discriminate between infections with herpes simplex virus types 1 and 2 Ann. Intern. Med. 115 1991 520 526
21. K.F. Karpinski, S. Hayward, and H. Tryphonas Statistical considerations in the quantitation of serum immunoglobulin levels using the enzyme-linked immunosorbent assay (ELISA) J. Immunol. Methods 103 1987 189 194
22. A.G. Langenberg, R.L. Burke, S.F. Adair, R. Sekulovich, M. Tigges, and C.L. Dekker A recombinant glycoprotein vaccine for herpes simplex virus type 2: safety and immunogenicity Ann. Intern. Med. 122 1995 889 898 Erratum, Ann. Intern. Med. 123 (1995) 395
23. S.M. Garland, T.N. Lee, R.L. Ashley, L. Corey, and S.L. Sacks Automated microneutralization: method and comparison with Western blot for type-specific detection of herpes simplex antibodies in two pregnant populations J. Virol. Methods 55 1995 285 294
24. C.J. Clopper, and E.S. Pearson The use of confidence or fiducial limits illustrated in the case of binomial Biometrika 26 1934 404 413
25. C. Pedersen, T. Petaja, G. Strauss, H.C. Rumke, A. Poder, and J.H. Richardus Immunization of early adolescent females with human papillomavirus type 16 and 18 L1 virus-like particle vaccine containing AS04 adjuvant J. Adolesc. Health 40 2007 564 571